Factors Compromising Antibiotic Activity Against Biofilms of Staphylococcus epidermidis

[1]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[2]  M. Sugai,et al.  Effect of the Growth Rate of Pseudomonas aeruginosa Biofilms on the Susceptibility to Antimicrobial Agents: β-Lactams and Fluoroquinolones , 1999, Chemotherapy.

[3]  R. Scopes,et al.  Analysis of Proteins , 1998 .

[4]  Tsuyoshi Otani,et al.  In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.

[5]  J. Struthers,et al.  The use of Sorbarod biofilms to study the antimicrobial susceptibility of a strain of Streptococcus pneumoniae. , 1997, The Journal of antimicrobial chemotherapy.

[6]  J. Hacker,et al.  Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates , 1997, Infection and immunity.

[7]  G. Peters,et al.  A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces , 1997, Infection and immunity.

[8]  A. Veis,et al.  A method for enhancing the sensitivity and stability of stains-all for phosphoproteins separated in sodium dodecyl sulfate-polyacrylamide gels. , 1996, Analytical biochemistry.

[9]  S. Gander.  Bacterial biofllms: resistance to antimicrobial agents J Anlimicrob Chemother 1996; 37: 1047–1050 , 1996 .

[10]  S. Gander.  Bacterial biofilms: resistance to antimicrobial agents. , 1996, The Journal of antimicrobial chemotherapy.

[11]  P. Suci,et al.  Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms , 1994, Antimicrobial Agents and Chemotherapy.

[12]  D. Musher,et al.  Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. , 1994, The Journal of infectious diseases.

[13]  J. Heesemann,et al.  Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin , 1994, Infection and immunity.

[14]  A. Widmer,et al.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. , 1994, The Journal of antimicrobial chemotherapy.

[15]  G. Peters,et al.  Comparative analysis of a biofilm-forming Staphylococcus epidermidis strain and its adhesion-positive, accumulation-negative mutant M7. , 1994, FEMS microbiology letters.

[16]  S. J. Knott,et al.  Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. , 1994, The Journal of antimicrobial chemotherapy.

[17]  T. Yokota,et al.  Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis , 1994, Antimicrobial Agents and Chemotherapy.

[18]  D. Goldmann,et al.  Occurrence of capsular polysaccharide/adhesin among clinical isolates of coagulase-negative staphylococci. , 1993, The Journal of infectious diseases.

[19]  D. Goldmann,et al.  Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime , 1993, Infection and immunity.

[20]  J. Morgan,et al.  A study of coagulase-negative staphylococci with reference to slime production, adherence, antibiotic resistance patterns and clinical significance. , 1992, The Journal of hospital infection.

[21]  J. Costerton,et al.  Mechanism of persistent infection associated with peritoneal implants. , 1992, Journal of medical microbiology.

[22]  J. Costerton,et al.  Kinetic interaction of biofilm cells of Staphylococcus aureus with cephalexin and tobramycin in a chemostat system , 1992, Antimicrobial Agents and Chemotherapy.

[23]  A. Widmer,et al.  Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections , 1991, Antimicrobial Agents and Chemotherapy.

[24]  M. R. Brown,et al.  Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response , 1990, Antimicrobial Agents and Chemotherapy.

[25]  F. Pérez,et al.  Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. , 1990, Reviews of infectious diseases.

[26]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[27]  B. Farber,et al.  Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. , 1990, The Journal of infectious diseases.

[28]  L. Baddour,et al.  Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo , 1987, Infection and immunity.

[29]  J. Costerton,et al.  Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.

[30]  A. Tomasz,et al.  The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. , 1986, Journal of general microbiology.

[31]  M. R. Brown,et al.  Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. , 1985, The Journal of antimicrobial chemotherapy.

[32]  A. Bisno,et al.  Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis , 1983, Infection and immunity.

[33]  W. Nichols,et al.  Antibiotic penetration through bacterial capsules and exopolysaccharides. , 1982, The Journal of antimicrobial chemotherapy.

[34]  W. Nichols,et al.  THE PENETRATION OF ANTIBIOTICS THROUGH SODIUM ALGINATE AND THROUGH THE EXOPOLYSACCHARIDE OF A MUCOID STRAIN OF PSEUDOMONAS AERUGINOSA , 1981, The Lancet.